Related Experiment Video
Updated: May 22, 2026

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
Published on: August 17, 2022
The anaemia of Plasmodium vivax malaria
Nicholas M Douglas1, Nicholas M Anstey, Pierre A Buffet
1Global Health Division, Menzies School of Health Research, PO Box 41096, Casuarina, NT 0811, Australia. nicholas.douglas@gmail.com
Insights
Plasmodium vivax malaria causes significant anemia, especially in young children. Early treatment of this Plasmodium vivax infection is crucial to prevent severe anemia and its complications.
Area of Science:
- Malariology
- Hematology
- Global Health
Background:
- Plasmodium vivax malaria affects nearly half the global population.
- It is a major cause of anemia, hindering development goals.
- The pathogenesis of vivax-associated anemia is not fully understood.
Purpose of the Study:
- To review current evidence on Plasmodium vivax-associated anemia.
- To synthesize information on its epidemiology, pathogenesis, treatment, and consequences.
Main Methods:
- Literature review of current evidence.
- Synthesis of data on Plasmodium vivax anemia.
Main Results:
- Young children in high-transmission areas with frequent relapses are at high risk.
- Plasmodium vivax causes significant red blood cell mass reduction by removing uninfected red blood cells.
- Severe anemia leads to indirect mortality and morbidity, including complications in pregnancy and need for transfusions.
Conclusions:
- Plasmodium vivax is a critical cause of anemia, particularly in vulnerable populations.
- Effective anti-malarial treatment can prevent anemia associated with Plasmodium vivax.
- Addressing Plasmodium vivax malaria is essential for global health and development.
Abstract:
Plasmodium vivax threatens nearly half the world's population and is a significant impediment to achievement of the millennium development goals. It is an important, but incompletely understood, cause of anaemia. This review synthesizes current evidence on the epidemiology, pathogenesis, treatment and consequences of vivax-associated anaemia. Young children are at high risk of clinically significant and potentially severe vivax-associated anaemia, particularly in countries where transmission is intense and relapses are frequent. Despite reaching lower densities than Plasmodium falciparum, Plasmodium vivax causes similar absolute reduction in red blood cell mass because it results in proportionately greater removal of uninfected red blood cells. Severe vivax anaemia is associated with substantial indirect mortality and morbidity through impaired resilience to co-morbidities, obstetric complications and requirement for blood transfusion. Anaemia can be averted by early and effective anti-malarial treatment.
More Related Videos
Related Concept Videos
Symbiosis
Diversity of Protists II
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Fungal Phylum Microsporidia
Graves Disease II: Pathophysiology
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...

